Agilon Health Inc.
AGL | NYSE
$88.03
-$1.13 (-1.27%)
At close: Sep 21, 2026, 4:00 PM ET
$88.03
$0 (0.00%)
After-hours:
Sep 21, 2026, 4:00 PM ET
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Feb 17, 2021 |
|---|---|---|---|---|---|---|
Revenue | 5.93B | 6.06B | 4.32B | 2.39B | 1.52B | 1.22B |
Cost of Revenue | 6.12B | 6.06B | 4.25B | 2.28B | 1.46B | 1.12B |
Gross Profit | -188.61M | 4.84M | 69.67M | 111.36M | 65.74M | 94.15M |
Operating Income | -421.08M | -292.13M | -232.13M | -105.38M | -372.24M | -56.67M |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -404.1M | -248.83M | -194.46M | -90.67M | -382.98M | -62.34M |
Net Income | -405.35M | -260.15M | -262.6M | -106.55M | -406.49M | -60.05M |
Selling & General & Admin | 238.54M | 268.91M | 285.76M | 207.79M | 427.5M | 137.29M |
Research & Development | n/a | n/a | n/a | n/a | n/a | n/a |
Other Expenses | -6.08M | 28.06M | 16.04M | 8.95M | 10.48M | 13.53M |
Operating Expenses | 232.46M | 296.97M | 301.8M | 216.74M | 437.99M | 150.82M |
Interest Expense | 6.64M | 6.18M | 6.66M | 4.48M | 6.15M | 8.14M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 6.35B | 6.35B | 4.55B | 2.49B | 1.89B | 1.28B |
Income Tax Expense | 1.25M | 1.45M | 791K | 1.64M | 886K | 865K |
Shares Outstanding (Basic) | 16.56M | 16.44M | 16.36M | 16.33M | 14.92M | 15.39M |
Shares Outstanding (Diluted) | 16.56M | 16.44M | 16.36M | 16.33M | 14.92M | 15.39M |
EPS (Basic) | -24.50 | -15.75 | -16 | -6.50 | -27.25 | -4 |
EPS (Diluted) | -24.50 | -15.75 | -16 | -6.50 | -27.25 | -4 |
EBITDA | -368.86M | -218.19M | -167.64M | -72.41M | -362.16M | -40.11M |
EBIT | -397.46M | -242.65M | -187.8M | -86.19M | -376.83M | -54.21M |
Depreciation & Amortization | 28.59M | 24.46M | 20.16M | 13.77M | 14.67M | 14.1M |
Add to Watchlist
Select watchlists to add or remove AGL